Cover Image
Market Research Report
Product code 
1103461

Colorectal Cancer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality (Diagnosis Type, Therapy Type, and Imaging Type) and End User (Hospitals and Diagnostic & Research Laboratories)

Published: | The Insight Partners | 259 Pages | Delivery time: 1-2 business days

Price

Back to Top
Colorectal Cancer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality (Diagnosis Type, Therapy Type, and Imaging Type) and End User (Hospitals and Diagnostic & Research Laboratories)
Published: June 13, 2022
The Insight Partners
Content info: 259 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The global colorectal cancer market is expected to grow from US$ 18,619.3 million in 2022 to US$ 24,078.5 million by 2028; it is expected to grow at a CAGR of 3.3% from 2022 to 2028.

Factors such as the increasing prevalence of colorectal cancer, product launches, and benefits offered by generic drugs are driving the growth of the global colorectal cancer market. However, pricing pressure on drug manufacturers is hampering the global colorectal cancer market growth.

Colorectal cancer, also known as bowel cancer, colon cancer, or rectal cancer, is any form of cancer that affects the colon and the rectum. Colon and rectal cancer are often grouped together as many features are common in them. The majority of colorectal cancers generally develop over time from adenomatous (precancerous) polyps. Colorectal cancer may be benign, or non-cancerous, or malignant. Some of the risk factors for colorectal cancer involve a family history of colon or rectal cancer, diet, alcohol intake, smoking and inflammatory bowel disease. The symptoms shown by the patients who have colon cancer include changes in bowel habits, diarrhea or constipation, blood in stools that make it look black. Colorectal cancer can be treated with chemotherapy, radiotherapy, and surgery.

The increasing medical tourism and the growing pharmaceutical industry in emerging countries are expected to boost the global colorectal cancer market growth. According to India Brand Equity Foundation (IBEF) statistics in April 2019, India is the largest provider of generic drugs worldwide. The Indian pharmaceutical industry supplies ~40% of generic demand in the US, with ~50% of the global demand for multiple vaccines and 25% of all medicines in the UK. The pharmaceutical sector in India is expected to grow from US$ 42 billion in 2021 to US$ 55 billion by 2025; it is estimated to register at a CAGR of 37% from 2020 to 2025. Moreover, India has a huge pool of scientists and engineers having the potential to grow the healthcare industry remarkably.

Major market players focus on emerging markets such as Singapore and China as they have many colorectal cancer patients and growing medical tourism. As per the Australian Institute of Health and Welfare, over ~15,540 new cases of colorectal cancer were diagnosed in 2021. Moreover, as per the Malaysia Healthcare Travel Council, in 2019, over 1.22 million healthcare travelers visited Malaysia for healthcare purposes. The low cost of treatment and incorporation of advanced technologies to provide less waiting time for procedures in Asia Pacific are likely to boost the number of surgeries. This ultimately increases the demand for colorectal cancer diagnostics and treatment.

Many key market players are involved in manufacturing a wide range of drugs and diagnostic tests that help in reducing the burden of colorectal cancer. For instance, in June 2021, Bristol Myers Squibb announced the approval of Opdivo plus Yervoy by the European Commission (EC) for the treatment of adult patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer. In July 2020, Taiho Pharmaceutical Co., Ltd. launched LONSURF, its anticancer agent, for the treatment of patients with metastatic colorectal cancer. With the launch of this product in China, the company expected that Lonsurf would offer a broader contribution to patients and medical institutions as a new treatment option for patients with colorectal cancer. Furthermore, inorganic developments by the key players of the global colorectal cancer market will also help the market to grow. For instance, Epigenomics AG announced its Next Generation Liquid Biopsy Test for colorectal cancer screening and planned to appeal the National Coverage Determination (NCD) decision in 2021. Thus, the constant developments and new product launches in colorectal cancer diagnostics and therapeutics are driving the global colorectal cancer market growth.

The global colorectal cancer market is bifurcated into modality and end user. Based on modality, the global colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. The diagnosis type segment is estimated to account for the largest market share and is expected to register the highest CAGR during the forecast period. Colorectal cancer or CRC is the most frequent human malignant neoplasms. The diagnostics emphasize the need for early recognition of neoplasms in the asymptomatic or precancerous stage. Therefore, early recognition is essential in patients with acute symptoms and adverse course of the disease. The diagnosis type segment holds the largest share of the global colorectal cancer market in 2022. The diagnosis type is further segmented into immunohistochemistry, stool test, flexible sigmoidoscopy, colonoscopy, CEA test, and others. Moreover, the stool test segment is anticipated to register the highest CAGR in the market during the forecast period. Stool-based tests are noninvasive for colorectal cancer screening options. For this test, no special diet or bowel preparation is required. Stool-based tests are recommended for patients with an average risk for colorectal cancer or no personal history. Further, guaiac-based fecal occult blood test (gFOBT) and fecal immunochemical test (FIT) are the noninvasive tests practiced to find blood in the stool that may be a symptom of cancer or large polyps. These tests can be taken at home with a kit after following instructions. Another type of noninvasive test is Stool DNA testing, which looks for certain DNA or gene changes that often get into the stool, which can be a sign of cancer if a stool DNA test results in abnormal. Fecal occult blood testing (FOBT) is the most widely prescribed screening test for CRC as it is simple, noninvasive, and has been demonstrated to reduce the chances of death due to CRC. For instance, Clinical Genomics Technologies Pty Ltd offers InSure ONE (Fecal Immunochemical testing) for detecting blood in the stool, which helps to diagnose CRC.

The World Health Organization (WHO), American Cancer Society, Centers for Disease Control and Prevention (CDC), and GLOBOCAN: Global Cancer Observatory are among the primary and secondary sources referred to while preparing the report on the global colorectal cancer market.

Reasons to Buy:

A brief idea about the current competition in the Colorectal Cancer Market.

Highlights key business priorities and focus in order to assist companies to realign their business strategies.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

The key findings and recommendations highlight crucial progressive industry trends in the global Colorectal Cancer market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Provide strong and enough study of Colorectal Cancer market that help in understanding the market.

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global Colorectal Cancer market.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Product Code: TIPRE00006881

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Colorectal Cancer Market - By Modality
    • 1.3.2 Global Colorectal Cancer Market - By End User
    • 1.3.3 Global Colorectal Cancer Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Colorectal Cancer- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Colorectal Cancer Market - North America PEST Analysis
    • 4.2.2 Colorectal Cancer Market - Europe PEST Analysis
    • 4.2.3 Colorectal Cancer Market - Asia Pacific PEST Analysis
    • 4.2.4 Colorectal Cancer Market - Middle East & Africa PEST Analysis
    • 4.2.5 Colorectal Cancer Market - South And Central America PEST Analysis
  • 4.3 Expert Opinion

5. Global Colorectal Cancer Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Colorectal Cancer
    • 5.1.2 New Product Launches
    • 5.1.3 Benefits Offered by Generic Drugs
  • 5.2 Market Restraints
    • 5.2.1 Pricing Pressure on Drug Manufacturers
  • 5.3 Market Opportunities
    • 5.3.1 Growing Pharmaceutical Industry in Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Inclination Toward Personalized Medicine
  • 5.5 Impact Analysis

6. Global Colorectal Cancer Market- Global Analysis

  • 6.1 Global Colorectal Cancer Market Revenue Forecast and Analysis
    • 6.1.1 Overview
    • 6.1.2 Global Colorectal Cancer Market, By Geography - Forecasts And Analysis
    • 6.1.3 Global Colorectal Cancer Market- Market Potential Analysis, By Region
  • 6.2 Company Analysis
    • 6.2.1 Market Share Analysis of Key Players in Global Colorectal Cancer Market (2021)
    • 6.2.2 Comparative Company Analysis
    • 6.2.3 Growth Strategy Analysis
    • 6.2.4 Performance of Key Players
      • 6.2.4.1 Abbott
      • 6.2.4.2 F. Hoffmann-La Roche AG

7. Global Colorectal Cancer Market Analysis - By Modality

  • 7.1 Overview
  • 7.2 Global Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)
  • 7.3 Diagnosis Type
    • 7.3.1 Overview
    • 7.3.2 Diagnosis Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.3 Immunohistochemistry
      • 7.3.3.1 Overview
      • 7.3.3.2 Immunohistochemistry: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.4 Stool Test
      • 7.3.4.1 Overview
      • 7.3.4.2 Stool Test : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.5 Flexible Sigmoidoscopy
      • 7.3.5.1 Overview
      • 7.3.5.2 Flexible Sigmoidoscopy : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.6 Colonoscopy
      • 7.3.6.1 Overview
      • 7.3.6.2 Colonoscopy : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.7 CEA Test
      • 7.3.7.1 Overview
      • 7.3.7.2 CEA Test : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.3.8 Other Test
      • 7.3.8.1 Overview
      • 7.3.8.2 Other Test : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Therapy Type
    • 7.4.1 Overview
    • 7.4.2 Global Therapy Type : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4.3 Chemotherapy
      • 7.4.3.1 Overview
      • 7.4.3.2 Chemotherapy : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.3.3 Alkylating Agent
        • 7.4.3.3.1 Overview
        • 7.4.3.3.2 Alkylating Agent : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.3.4 Antimetabolites
        • 7.4.3.4.1 Antimetabolites : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.3.5 Others
        • 7.4.3.5.1 Others : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4.4 Immunotherapy
      • 7.4.4.1 Overview
      • 7.4.4.2 Immunotherapy : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.4.3 Panitumumab
        • 7.4.4.3.1 Overview
        • 7.4.4.3.2 Panitumumab : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.4.4 Cetuximab
        • 7.4.4.4.1 Overview
        • 7.4.4.4.2 Cetuximab : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.4.5 Bevacizumab
        • 7.4.4.5.1 Overview
        • 7.4.4.5.2 Bevacizumab : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.4.6 Others
        • 7.4.4.6.1 Overview
        • 7.4.4.6.2 Others : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4.5 Chemoprotectant
      • 7.4.5.1 Overview
      • 7.4.5.2 Chemoprotectant : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4.6 Others
      • 7.4.6.1 Overview
      • 7.4.6.2 Others : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Imaging Type
    • 7.5.1 Overview
    • 7.5.2 Global Imaging Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.5.3 Computed Tomography (CT)
      • 7.5.3.1 Overview
      • 7.5.3.2 Computed Tomography (CT) : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.5.4 Magnetic Resonance Imaging (MRI)
      • 7.5.4.1 Overview
      • 7.5.4.2 Magnetic Resonance Imaging (MRI) : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.5.5 Others
      • 7.5.5.1 Overview
      • 7.5.5.2 Others : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Colorectal Cancer Market Revenue and Forecast To 2028 - By End User

  • 8.1 Overview
  • 8.2 Global Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Diagnostic and Research Laboratories
    • 8.4.1 Overview
    • 8.4.2 Diagnostic and Research Laboratories : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Colorectal Cancer Market Revenue and Forecast to 2028 - Geographical Analysis

  • 9.1 North America: Colorectal Cancer Market
    • 9.1.1 Overview
    • 9.1.2 North America: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
    • 9.1.3 North America: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
      • 9.1.3.1 North America: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
      • 9.1.3.2 North America: Colorectal Cancer Market, by Therapy Type - 2019-2028 (US$ Million)
        • 9.1.3.2.1 North America: Colorectal Cancer Market, by Chemotherapy- 2019-2028 (US$ Million)
        • 9.1.3.2.2 North America: Colorectal Cancer Market, by Immunotherapy- 2019-2028 (US$ Million)
      • 9.1.3.3 North America: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
    • 9.1.4 North America: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
    • 9.1.5 North America: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
      • 9.1.5.1 US: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.1 US: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.1.2 US: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.1.5.1.2.1 US: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.1.5.1.2.2 US: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.1.5.1.2.2.1. US: Colorectal Cancer Market, by Chemotherapy- 2019-2028 (US$ Million)
        • 9.1.5.1.2.2.2. US: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.1.5.1.2.3 US: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.1.5.1.3 US: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.1.5.2 Canada: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.1 Canada: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.2.2 Canada: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.1.5.2.2.1 Canada: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 1.1.5.2.1.1 Canada: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.1.5.2.2.1.1. Canada: Colorectal Cancer Market, by Chemotherapy- 2019-2028 (US$ Million)
        • 9.1.5.2.2.1.2. Canada: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.1.5.2.2.2 Canada: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.1.5.2.3 Canada: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.1.5.3 Mexico: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.1 Mexico: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
        • 9.1.5.3.2 Mexico: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.1.5.3.2.1 Mexico: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.1.5.3.2.2 Mexico: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.1.5.3.2.2.1. Mexico: Colorectal Cancer Market, by Chemotherapy- 2019-2028 (US$ Million)
        • 9.1.5.3.2.2.2. Mexico: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.1.5.3.2.3 Mexico: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.1.5.3.3 Mexico: Colorectal Cancer Market - Revenue and Forecast To 2028, By End Users (US$ Million)
  • 9.2 Europe: Colorectal Cancer Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.3 Europe: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
      • 9.2.3.1 Europe: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
      • 9.2.3.2 Europe: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.2.3.2.1 Europe: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.2.3.2.2 Europe: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
      • 9.2.3.3 Europe: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
    • 9.2.4 Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
    • 9.2.5 Europe: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
      • 9.2.5.1 Germany: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.1 Germany: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.1.2 Germany: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.2.5.1.2.1 Germany: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.2.5.1.2.2 Germany: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.2.5.1.2.2.1. Germany: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.1.2.2.2. Germany: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.1.2.3 Germany: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.2.5.1.3 Germany: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.2.5.2 France: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.1 France: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.2.2 France: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.2.5.2.2.1 France: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.2.5.2.2.2 France: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.2.5.2.2.2.1. France: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.2.2.2.2. France: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.2.2.3 France: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.2.5.2.3 France: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.2.5.3 UK: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.1 UK: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.3.2 UK: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.2.5.3.2.1 UK: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.2.5.3.2.2 UK: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.2.5.3.2.2.1. UK: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.3.2.2.2. UK: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.3.2.3 UK: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.2.5.3.3 UK: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.2.5.4 Italy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.1 Italy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.4.2 Italy: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.2.5.4.2.1 Italy: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.2.5.4.2.2 Italy: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.2.5.4.2.2.1. Italy: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.4.2.2.2. Italy: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.4.2.3 Italy: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.2.5.4.3 Italy: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.2.5.5 Spain: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.1 Spain: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.5.2 Spain: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.2.5.5.2.1 Spain: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.2.5.5.2.2 Spain: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.2.5.5.2.2.1. Spain: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.5.2.2.2. Spain: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.5.2.3 Spain: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.2.5.5.3 Spain: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.2.5.6 Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.1 Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.2.5.6.2 Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.2.5.6.2.1 Rest of Europe: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.2.5.6.2.2 Rest of Europe: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.2.5.6.2.2.1. Rest of Europe: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.6.2.2.2. Rest of Europe: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.2.5.6.2.3 Rest of Europe: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.2.5.6.3 Rest of Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • 9.3 Asia Pacific Colorectal Cancer Market Revenue and Forecast to 2028
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
    • 9.3.3 Asia Pacific: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
      • 9.3.3.1 Asia Pacific: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
      • 9.3.3.2 Asia Pacific Therapy Type Market Revenue and Forecasts to 2028, By Therapy Type (US$ Million)
        • 9.3.3.2.1 Asia Pacific Chemotherapy Market Revenue and Forecasts to 2028, By Chemotherapy (US$ Million)
        • 9.3.3.2.2 Asia Pacific Immunotherapy Market Revenue and Forecasts to 2028, By Immunotherapy (US$ Million)
      • 9.3.3.3 Asia Pacific Imaging Type Market Revenue and Forecasts to 2028, By Imaging Type (US$ Million)
    • 9.3.4 Asia Pacific : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
    • 9.3.5 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)
      • 9.3.5.1 China Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.3.5.1.1 China Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.3.5.1.2 China: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.3.5.1.2.1 China: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.3.5.1.2.2 China: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.3.5.1.2.2.1. China: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.1.2.2.2. China: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.1.2.3 China: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
        • 9.3.5.1.3 China : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.3.5.2 Japan Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.3.5.2.1 Japan Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.3.5.2.2 Japan: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.3.5.2.2.1 Japan: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.3.5.2.2.2 Japan: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.3.5.2.2.2.1. Japan: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.2.2.2.2. Japan: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.2.2.3 Japan: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
        • 9.3.5.2.3 Japan : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.3.5.3 India Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.3.5.3.1 India Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.3.5.3.2 India: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.3.5.3.2.1 India: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.3.5.3.2.2 India: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.3.5.3.2.2.1. India: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.3.2.2.2. India: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.3.2.3 India: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
        • 9.3.5.3.3 India : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.3.5.4 South Korea Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.3.5.4.1 South Korea Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.3.5.4.2 South Korea: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.3.5.4.2.1 South Korea: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.3.5.4.2.2 South Korea: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.3.5.4.2.2.1. South Korea: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.4.2.2.2. South Korea: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.4.2.3 South Korea: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
        • 9.3.5.4.3 South Korea : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.3.5.5 Australia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.3.5.5.1 Australia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.3.5.5.2 Australia: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.3.5.5.2.1 Australia: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.3.5.5.2.2 Australia: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.3.5.5.2.2.1. Australia: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.5.2.2.2. Australia: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.5.2.3 Australia: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
        • 9.3.5.5.3 Australia : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.3.5.6 Rest of Asia Pacific: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
        • 9.3.5.6.1 Overview
        • 9.3.5.6.2 Rest of Asia Pacific: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.3.5.6.3 Rest of Asia Pacific:: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.3.5.6.3.1 Rest of Asia Pacific:: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.3.5.6.3.2 Rest of Asia Pacific:: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.3.5.6.3.2.1. Rest of Asia Pacific:: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.6.3.2.2. Rest of Asia Pacific:: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.3.5.6.3.3 Rest of Asia Pacific:: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
        • 9.3.5.6.4 Rest of Asia Pacific: : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • 9.4 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2028
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
    • 9.4.3 Middle East & Africa: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
      • 9.4.3.1 Middle East & Africa: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
      • 9.4.3.2 Middle East & Africa: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.4.3.2.1 Middle East & Africa: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.4.3.2.2 Middle East & Africa: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
      • 9.4.3.3 Middle East & Africa: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
    • 9.4.4 Middle East & Africa : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
    • 9.4.5 Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)
      • 9.4.5.1 UAE Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.4.5.1.1 UAE Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.4.5.1.2 UAE: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.4.5.1.2.1 UAE: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.4.5.1.2.2 UAE: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.4.5.1.2.2.1. UAE: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.4.5.1.2.2.2. UAE: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.4.5.1.2.3 UAE: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
        • 9.4.5.1.3 UAE : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.4.5.2 Saudi Arabia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.4.5.2.1 Saudi Arabia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.4.5.2.2 Saudi Arabia: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.4.5.2.2.1 Saudi Arabia: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.4.5.2.2.2 Saudi Arabia: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.4.5.2.2.2.1. Saudi Arabia: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.4.5.2.2.2.2. Saudi Arabia: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.4.5.2.2.3 Saudi Arabia: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
        • 9.4.5.2.3 Saudi Arabia : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.4.5.3 South Africa Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.4.5.3.1 South Africa Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
        • 9.4.5.3.2 South Africa: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.4.5.3.2.1 South Africa: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.4.5.3.2.2 South Africa: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.4.5.3.2.2.1. South Africa: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.4.5.3.2.2.2. South Africa: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.4.5.3.2.3 South Africa: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
        • 9.4.5.3.3 South Africa : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
      • 9.4.5.4 Rest of Middle East and Africa: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.4.5.4.1 Overview
        • 9.4.5.4.2 Rest of Middle East and Africa: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
        • 9.4.5.4.3 Rest of Middle East and Africa:: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.4.5.4.3.1 Rest of Middle East and Africa:: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.4.5.4.3.2 Rest of Middle East and Africa:: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
        • 9.4.5.4.3.2.1. Rest of Middle East and Africa:: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.4.5.4.3.2.2. Rest of Middle East and Africa:: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.4.5.4.3.3 Rest of Middle East and Africa:: Colorectal Cancer Market, by Imaging Type- 2019- 2028 (US$ Million)
        • 9.4.5.4.4 Rest of Middle East and Africa: : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • 9.5 South and Central America: Colorectal Cancer Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.5.3 South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
      • 9.5.3.1 South and Central America: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
      • 9.5.3.2 South and Central America: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.5.3.2.1 South and Central America: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.5.3.2.2 South and Central America: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
      • 9.5.3.3 South and Central America: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
    • 9.5.4 South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028, By End User (US$ Million)
    • 9.5.5 South and Central America: Colorectal Cancer Market Share, by Country (2022 & 2028) (%)
      • 9.5.5.1 Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.1.1 Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.1.2 Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.5.5.1.2.1 Brazil: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.5.5.1.2.2 Brazil: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.5.5.1.2.2.1. Brazil: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.5.5.1.2.2.2. Brazil: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.5.5.1.2.3 Brazil: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.5.5.1.3 Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028, By End Users (US$ Million)
      • 9.5.5.2 Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.2.1 Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.2.2 Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.5.5.2.2.1 Argentina: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.5.5.2.2.2 Argentina: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.5.5.2.2.2.1. Argentina: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.5.5.2.2.2.2. Argentina: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.5.5.2.2.3 Argentina: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.5.5.2.3 Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028, By End Users (US$ Million)
      • 9.5.5.3 Rest of South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.3.1 Rest of South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.5.5.3.2 Rest of South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
        • 9.5.5.3.2.1 Rest of South and Central America: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
        • 9.5.5.3.2.2 Rest of South and Central America: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
        • 9.5.5.3.2.2.1. Rest of South and Central America: Colorectal Cancer Market, by Chemotherapy- 2019- 2028 (US$ Million)
        • 9.5.5.3.2.2.2. Rest of South and Central America: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
        • 9.5.5.3.2.3 Rest of South and Central America: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
        • 9.5.5.3.3 Rest of South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028, By End Users (US$ Million)

10. Impact of COVID-19 Pandemic on Geographic Regions

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Global Colorectal Cancer Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028
  • 11.3 Organic Developments
    • 11.3.1 Overview
    • 11.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028
  • 11.4 Inorganic Developments
    • 11.4.1 Overview
    • 11.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028

12. Company Profiles

  • 12.1 Epigenomics AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Novigenix SA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Clinical Genomics Technologies Pty. Ltd.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Abbott
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Amgen Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 F. HOFFMANN-LA ROCHE LTD.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Bruker Corporation
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Quest Diagnostics Incorporated
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 EDP Biotech Corporation
    • 12.9.1 Business Description
    • 12.9.2 Products and Services
    • 12.9.3 Financial Overview
    • 12.9.4 SWOT Analysis
    • 12.9.5 Key Developments
  • 12.10 Volitionrx Limited
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 2. North America: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America: Colorectal Cancer Market, by Chemotherapy- - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. North America: Colorectal Cancer Market, by Immunotherapy- Revenue and Forecast To 2028 (US$ Million)
  • Table 6. North America: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. North America: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 8. US: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 9. US: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. US: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. US: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. US: Colorectal Cancer Market, by Immunotherapy- Revenue and Forecast To 2028 (US$ Million)
  • Table 13. US: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. US: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 15. Canada: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 16. Canada: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Canada: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Canada: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Canada: Colorectal Cancer Market, by Immunotherapy- Revenue and Forecast To 2028 (US$ Million)
  • Table 20. Canada: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Canada: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 22. Mexico: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 23. Mexico: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Mexico: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Mexico: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Mexico: Colorectal Cancer Market, by Immunotherapy- Revenue and Forecast To 2028 (US$ Million)
  • Table 27. Mexico: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Mexico: Colorectal Cancer Market - Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 29. Europe: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 30. Europe: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Europe: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Europe: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Europe: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Europe: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 36. Germany: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 37. Germany: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Germany: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Germany: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Germany: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Germany: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Germany: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 43. France: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 44. France: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. France: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. France: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. France: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. France: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. France: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 50. UK: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 51. UK: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. UK: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. UK: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. UK: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. UK: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. UK: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 57. Italy: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 58. Italy: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Italy: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Italy: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Italy: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Italy: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Italy: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 64. Spain: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 65. Spain: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Spain: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Spain: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Spain: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Spain: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Spain: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 71. Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 72. Rest of Europe: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Rest of Europe: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Rest of Europe: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Rest of Europe: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Rest of Europe: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Rest of Europe: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 78. Asia Pacific: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 79. Asia Pacific Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Asia Pacific Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Asia Pacific Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Asia Pacific Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 83. Asia Pacific Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 84. Asia Pacific: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 85. China Colorectal Cancer Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 86. China Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 87. China Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 88. China Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 89. China Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 90. China Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 91. China: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 92. Japan Colorectal Cancer Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 93. Japan Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 94. Japan Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 95. Japan Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 96. Japan Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 97. Japan Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 98. Japan: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 99. India Colorectal Cancer Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 100. India Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 101. India Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 102. India Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 103. India Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 104. India Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 105. India: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 106. South Korea Colorectal Cancer Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 107. South Korea Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 108. South Korea Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 109. South Korea Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 110. South Korea Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 111. South Korea Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 112. South Korea: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 113. Australia Colorectal Cancer Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 114. Australia Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 115. Australia Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 116. Australia Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 117. Australia Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 118. Australia Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 119. Australia: Colorectal Cancer Market Revenue and Forecast to 2028, By End Users (US$ Million)
  • Table 120. Rest of Asia Pacific: Colorectal Cancer Market Revenue and Forecasts To 2028, By Modality (US$ Million)
  • Table 121. Rest of Asia Pacific: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 122. Rest of Asia Pacific: Therapy Type Market Revenue and Forecasts To 2028, By Type (US$ Million)
  • Table 123. Rest of Asia Pacific: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 124. Rest of Asia Pacific: Colorectal Cancer Market, byImmunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 125. Rest of Asia Pacific: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 126. Rest of Asia Pacific: Colorectal Cancer Market Revenue and Forecasts To 2028, By End User (US$ Million)
  • Table 127. Middle East and Africa Colorectal Cancer Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 128. Middle East and Africa Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 129. Middle East and Africa Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 130. Middle East and Africa Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 131. Middle East and Africa Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 132. Middle East and Africa Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 133. Middle East and Africa: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 134. UAE Colorectal Cancer Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 135. UAE Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 136. UAE Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 137. UAE Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 138. UAE Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 139. UAE Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 140. UAE: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 141. Saudi Arabia Colorectal Cancer Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 142. Saudi Arabia Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 143. Saudi Arabia Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 144. Saudi Arabia Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 145. Saudi Arabia Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 146. Saudi Arabia Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 147. Saudi Arabia: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 148. South Africa Colorectal Cancer Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 149. South Africa Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 150. South Africa Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 151. South Africa Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 152. South Africa Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 153. South Africa Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 154. South Africa: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
  • Table 155. Rest of Middle East and Africa: Colorectal Cancer Market Revenue and Forecasts To 2028, By Modality (US$ Million)
  • Table 156. Rest of Middle East and Africa: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 157. Rest of Middle East and Africa: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 158. Rest of Middle East and Africa: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 159. Rest of Middle East and Africa: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 160. Rest of Middle East and Africa: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 161. Rest of Middle East and Africa: Colorectal Cancer Market Revenue and Forecasts To 2028, By End User (US$ Million)
  • Table 162. South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 163. South and Central America: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 164. South and Central America: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 165. South and Central America: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 166. South and Central America: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 167. South and Central America: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 168. South and Central America Colorectal Cancer Market - Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 169. South and Central America Colorectal Cancer Market Share, by Country (2022 & 2028) (%)
  • Table 170. Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 171. Brazil: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 172. Brazil: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 173. Brazil: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 174. Brazil: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 175. Brazil: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 176. Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 177. Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 178. Argentina: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 179. Argentina: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 180. Argentina: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 181. Argentina: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 182. Argentina: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 183. Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028, By End Users (US$ Million)
  • Table 184. Rest of South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
  • Table 185. Rest of South and Central America: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 186. Rest of South and Central America: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 187. Rest of South and Central America: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 188. Rest of South and Central America: Colorectal Cancer Market, by Immunotherapy - Revenue and Forecast to 2028 (US$ Million)
  • Table 189. Rest of South and Central America: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 190. Rest of South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028, By End Users (US$ Million)
  • Table 191. Recent Organic Growth Strategies In The Colorectal Cancer Market
  • Table 192. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
  • Table 193. Glossary of Terms, Colorectal Cancer Market

List Of Figures

  • Figure 1. Colorectal Cancer Market Segmentation
  • Figure 2. Colorectal Cancer Segmentation, By Region
  • Figure 3. Global Colorectal Cancer Market Overview
  • Figure 4. Diagnosis Type Segment Held Largest Share Of Modality Segment In Colorectal Cancer Market
  • Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
  • Figure 6. Global Colorectal Cancer Market, By Geography (US$ Million)
  • Figure 7. Global Colorectal Cancer Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Colorectal Cancer Market, Industry Landscape
  • Figure 9. Colorectal Cancer Market - North America PEST Analysis
  • Figure 10. Colorectal Cancer Market - Europe PEST Analysis
  • Figure 11. Colorectal Cancer Market - Asia Pacific PEST Analysis
  • Figure 12. Colorectal Cancer Market - Middle East & Africa PEST Analysis
  • Figure 13. Colorectal Cancer Market - South and Central America PEST Analysis
  • Figure 14. Comparison of BrandED Drugs and Generic Drugs
  • Figure 15. Global Colorectal Cancer Market Impact Analysis of Drivers And Restraints
  • Figure 16. Global Colorectal Cancer Market - Revenue Forecasts And Analysis - 2020- 2028
  • Figure 17. Global Colorectal Cancer Market - By Geography Forecasts And Analysis - 2022- 2028
  • Figure 18. Global Colorectal Cancer Market - Market Potential Analysis, By Region
  • Figure 19. Market Positioning Of Key Player In Global Colorectal Cancer Market
  • Figure 20. Global Colorectal cancer Market - Comparative Company Analysis
  • Figure 21. Global Colorectal cancer market - Growth Strategy Analysis
  • Figure 22. Global Colorectal Cancer Market Revenue Share, by Modality 2022 & 2028 (%)
  • Figure 23. Diagnosis Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Immunohistochemistry: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Stool Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Flexible Sigmoidoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Colonoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. CEA Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Other Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Global Therapy Type : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Chemotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Alkylating Agent: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Antimetabolites: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Immunotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Panitumumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Cetuximab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Bevacizumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Chemoprotectant: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Global Imaging Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Computed Tomography (CT): Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Magnetic Resonance Imaging (MRI): Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Global Colorectal Cancer Market Revenue Share, by End User 2022 & 2028 (%)
  • Figure 47. Hospitals: : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Diagnostic and Research Laboratories : Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. North America: Colorectal Cancer Market Revenue Overview, By Key Country - Revenue (2022) (US$ Million)
  • Figure 50. North America: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 51. North America: Colorectal Cancer Market, By Country, 2022 & 2028 (%)
  • Figure 52. US: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 53. Canada: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 54. Mexico: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 55. Europe: Colorectal Cancer Market Revenue Overview, by Key Country - Revenue (2022) (US$ Million)
  • Figure 56. Europe Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. Europe: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
  • Figure 58. Germany: Colorectal Cancer Products Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. France: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. UK: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. Italy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Spain: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Rest of Europe: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Asia Pacific: Colorectal Cancer Market Revenue Overview, By Key Country - Revenue (2022) (US$ Million)
  • Figure 65. Asia Pacific: Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 66. Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 67. China Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 68. Japan Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 69. India Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 70. South Korea Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 71. Australia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 72. Rest of Asia Pacific: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 73. Middle East & Africa: Colorectal Cancer Market Revenue Overview, By Key Country - Revenue (2022) (US$ Million)
  • Figure 74. Middle East & Africa Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 75. Middle East & Africa Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 76. UAE Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 77. Saudi Arabia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 78. South Africa Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
  • Figure 79. Rest of Middle East and Africa: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 80. South and Central America Colorectal Cancer Market Overview, by Country (2022)
  • Figure 81. South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 82. Brazil: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 83. Argentina: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 84. Rest of South and Central America: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 85. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 86. Impact of COVID-19 Pandemic on European Country Markets
  • Figure 87. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 88. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 89. Impact of COVID-19 Pandemic on South & Central America Country Markets
  • Figure 90. Growth Strategies In The Colorectal Cancer Market, 2022-2028